Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Advanced Composites
LeftNav
Aerospace
LeftNav
Amorphous Metal Structures
LeftNav
Analysis and Simulation
LeftNav
Asbestos and Substitutes
LeftNav
Associations, Research Organisations and Universities
LeftNav
Automation Equipment
LeftNav
Automotive
LeftNav
Biomaterials
LeftNav
Building Materials
LeftNav
Bulk Handling and Storage
LeftNav
CFCs and Substitutes
LeftNav
Company
LeftNav
Components
LeftNav
Consultancy
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
 
News

A new product joins the service package for medical technology

BASF Aktiengesellschaft : 12 May, 2006  (New Product)
BASF has launched another plastic specialty for the field of medical technology. Terluran HD-15 is an acrylonitrile butadiene styrene that is being marketed with a service package tailor-made for the requirements of medical technology. This material belongs to the PlasticsPlus product line of the Styrene Plastics Operating Division. The abbreviation HD stands for 'Health Care and Diagnostics'.
BASF has launched another plastic specialty for the field of medical technology. Terluran HD-15 is an acrylonitrile butadiene styrene that is being marketed with a service package tailor-made for the requirements of medical technology. This material belongs to the PlasticsPlus product line of the Styrene Plastics Operating Division. The abbreviation HD stands for 'Health Care and Diagnostics'.

Thanks to its flow index of 15 ml/10 min, Terluran HD-15 is easy to process by injection molding. The new product surpasses conventional ABS particularly when it comes to its improved resistance to chemicals. Aside from this property, which is of utmost significance for manufacturers of technical medical products, Terluran HD also exhibits optimized toughness and rigidity values. Typical applications include the housings of inhalers.

Up until now, BASF had bundled its service package for Medical Technology with its transparent plastic Terlux 2802 HD (MABS). Features of this package are long-term formulation constancy, product purity and a wide array of basic experiments on chemical compatibility. 'The service package was well received by our MABS customers, so we have now expanded it to include our newly developed Terluran HD-15,' explains Dr. Axel Gottschalk, Business Manager for ABS specialties. This product is now commercially available.

Before manufacturers of medical equipment receive approval for their products, they have to meet stringent national and international statutory requirements. The approvals associated with Terluran HD-15, as was the case with the previously introduced Terlux 2802 HD, include conformity with the European Pharmacopoeia (EP 5th edition, Chapter 3.2.2) as well with the so-called Drug Master File, which facilitates obtaining approval in the United States.

An essential difference from a standard ABS also lies in the guarantee that customers will be informed at least 24 months in advance about any changes to the formulation that might become necessary. 'We could not provide this assurance of formulation constancy for a standard ABS,' explains Dr. Gottschalk. Another component of the service package includes biocompatibility testing for the raw material in accordance with international standards as well as technical support for applications.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 NewMaterials.com
Netgains Logo